Alyeska Investment Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-170,068
| Closed | -$15.5M | – | 739 |
|
|
2025
Q2 | $15.5M | Sell |
170,068
-724,912
| -81% | -$70.1M | 0.05% | 308 |
|
|
2025
Q1 | $101M | Buy |
+894,980
| New | +$95.7M | 0.4% | 68 |
|
|
2024
Q1 | – | Sell |
-306,663
| Closed | -$37.3M | – | 636 |
|
|
2023
Q4 | $37.3M | Buy |
+306,663
| New | +$34.2M | 0.25% | 127 |
|
|
2023
Q1 | – | Sell |
-451,933
| Closed | -$57.6M | – | 561 |
|
|
2022
Q4 | $57.6M | Buy |
+451,933
| New | +$52.4M | 0.6% | 50 |
|
|
2021
Q2 | – | Sell |
-208,067
| Closed | -$32.3M | – | 859 |
|
|
2021
Q1 | $32.3M | Buy |
208,067
+80,338
| +63% | +$12.4M | 0.42% | 65 |
|
|
2020
Q4 | $19.1M | Sell |
127,729
-65,363
| -34% | -$9.23M | 0.27% | 115 |
|
|
2020
Q3 | $25.5M | Buy |
+193,092
| New | +$25.2M | 0.39% | 77 |
|
|
2020
Q1 | – | Sell |
-12,532
| Closed | -$1.82M | – | 488 |
|
|
2019
Q4 | $1.82M | Buy |
+12,532
| New | +$1.73M | 0.02% | 297 |
|
|
2019
Q3 | – | Sell |
-23,235
| Closed | -$2.66M | – | 512 |
|
|
2019
Q2 | $2.66M | Sell |
23,235
-311,687
| -93% | -$36.5M | 0.03% | 293 |
|
|
2019
Q1 | $41.5M | Buy |
334,922
+249,465
| +292% | +$28.3M | 0.55% | 62 |
|
|
2018
Q4 | $8.61M | Buy |
+85,457
| New | +$9.61M | 0.13% | 184 |
|
|
2017
Q4 | – | Sell |
-1,050,468
| Closed | -$119M | – | 543 |
|
|
2017
Q3 | $119M | Buy |
1,050,468
+749,763
| +249% | +$86.5M | 0.89% | 20 |
|
|
2017
Q2 | $37.5M | Buy |
+300,705
| New | +$35.7M | 0.31% | 116 |
|
|
2016
Q4 | – | Sell |
-465,223
| Closed | -$58.7M | – | 558 |
|
|
2016
Q3 | $58.7M | Buy |
465,223
+6,657
| +1% | +$822K | 0.54% | 47 |
|
|
2016
Q2 | $53.6M | Buy |
+458,566
| New | +$51.9M | 0.5% | 58 |
|
|
2015
Q4 | – | Sell |
-51,927
| Closed | -$4.74M | – | 470 |
|
|
2015
Q3 | $4.74M | Sell |
51,927
-577,624
| -92% | -$57.9M | 0.06% | 256 |
|
|
2015
Q2 | $66.8M | Buy |
629,551
+315,537
| +100% | +$34.9M | 0.76% | 15 |
|
|
2015
Q1 | $35.8M | Buy |
+314,014
| New | +$35.8M | 0.5% | 53 |
|
|
2014
Q2 | – | Sell |
-265,467
| Closed | -$24.4M | – | 468 |
|
|
2014
Q1 | $24.4M | Buy |
265,467
+59,467
| +29% | +$5.48M | 0.67% | 33 |
|
|
2013
Q4 | $18.6M | Buy |
206,000
+51,500
| +33% | +$4.46M | 0.74% | 29 |
|
|
2013
Q3 | $12.3M | Buy |
+154,500
| New | +$12.2M | 0.5% | 71 |
|
Other funds holding ZBH
Alyeska Investment Group's ZBH Position: Q3 2025 in Review
Alyeska Investment Group sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 170,068 shares — an estimated $15.5M sold.
Alyeska Investment Group first reported a position in ZBH in Q3 2013 and held it in 21 quarters. The position peaked at $119M in Q3 2017. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Alyeska Investment Group reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Alyeska Investment Group sold 170,068 Zimmer Biomet shares in Q3 2025, an estimated $15.5M.
- Alyeska Investment Group first reported a position in Zimmer Biomet in Q3 2013 and held it in 21 quarters.
- Alyeska Investment Group's Zimmer Biomet position peaked at $119M in Q3 2017.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.